1 week ago
India’s Medical Tourism Startups Grow Despite Limited Venture Funding
Some companies help people travel to India for medical treatment.
They help patients choose hospitals, meet doctors and arrange visas, flights, hotels and care after treatment.
Patients come from many countries because treatment in India can cost much less.
Long waiting times in places such as the United Kingdom are also encouraging some people to look abroad.
Several startups say their businesses are growing quickly.
However, investors have provided only a small amount of funding to the whole sector.
Experts say these companies mostly provide services rather than building hospitals or other large assets.
That may make it harder for them to become very large businesses.
Some experts think they could eventually earn more from follow-up care or be bought by hospitals.
India’s medical-tourism startups coordinate hospitals, consultations, visas, travel, accommodation and post-treatment care.
Vaidam Health receives about 18,000 inquiries and serves more than 500 patients globally each month.
CureMeAbroad reports 21,500 monthly users, $5 million in annual recurring revenue and 73% quarter-on-quarter booked-case growth.
Foreign medical arrivals rose from about 180,000 in 2020 to more than 640,000 in 2024.
India’s 122 medical-tourism startups have raised only $9.28 million across 18 funding rounds.
- Who
- Indian medical-tourism startups, patients from overseas, investors and hospitals.
- What
- Startups are expanding services that coordinate overseas medical treatment, while the sector attracts limited venture funding.
- Where
- India, serving patients from Africa, the Middle East, the United Kingdom, the United States, Australia and more than 150 countries.
- When
- The article cites 2020-2025 arrival data, a 2026 market estimate and growth targets for this year.
- Why
- Lower treatment costs, long waiting times abroad and government support are increasing demand, while the service-based business model limits investor enthusiasm.
Growth and opportunity
Funding and scale concerns
Market potential
Growth and opportunity
Rising foreign-patient numbers, lower treatment costs and overseas waiting times are creating strong demand for Indian medical-tourism services.
Funding and scale concerns
The sector’s modest funding total suggests investors remain uncertain about whether demand can produce venture-scale returns.
Business model
Growth and opportunity
Startups are evolving beyond travel arrangements into medical coordination, complex-case management and post-treatment care, which could create additional revenue.
Funding and scale concerns
The companies remain largely asset-light service businesses dependent on intermediaries, potentially limiting value creation beyond a certain scale.
Future investment outcomes
Growth and opportunity
Investors have shown interest, and some providers could develop into B2B2C businesses or acquisition targets for hospitals.
Funding and scale concerns
The article does not identify major funding growth, and hospital acquisition potential remains an expectation rather than an established outcome.
Key facts
- Startups in India
- 122 medical-tourism startups, according to Tracxn.
- Sector funding
- $9.28 million raised across 18 funding rounds.
- Foreign arrivals
- More than 640,000 foreign medical arrivals in 2024; provisional 2025 numbers had already exceeded 500,000.
- Market forecast
- Mordor Intelligence estimates a $12.3 billion market in 2026, potentially exceeding $22 billion by 2031.
- Government estimate
- The government estimates $8.7 billion in 2025, rising to $16.2 billion by 2030.
- Visa access
- India has expanded e-Medical Visas to citizens of 167 countries.
- Vaidam Health activity
- About 18,000 inquiries and more than 500 patients served globally each month.
- CureMeAbroad activity
- More than 21,500 monthly users and $5 million in annual recurring revenue.
Quotes
Pankaj Chandna
Co-founder of Vaidam Health
“There is limited asset creation being done. It is more of a service business that is dependent on intermediaries, which could be an impediment to value creation beyond a certain scale”
financialexpress.com
“Our overall revenue has grown as we have increasingly focused on high-ticket and complex cases rather than patient volumes alone”
financialexpress.com











